Cells in culture become competent to replicate in the absence of growth factor after progressing beyond the late G1 restriction point, suggesting that a set of genes expressed during G1 phase is sucient to trigger completion of the cell cycle. However, this has not been demonstrated in an in vivo system. In this study, we examined whether transfection of genes associated with the G1/S transition could trigger hepatocyte replication. Co-transfection of cyclin E and skp2 synergistically promoted cell cycle progression in cultured primary hepatocytes in the absence of mitogen or in the presence of growth inhibitors. Furthermore, transfection of hepatocytes in vivo with cyclin E and skp2 promoted abundant hepatocyte replication and hyperplasia of the liver. These studies con®rm that transfection with a small number of genes can trigger proliferation of quiescent hepatocytes in vivo, and suggest that therapies to enhance liver regeneration by targeting cell cycle control genes may be feasible. Oncogene (2001) 20, 1825 ± 1831.
Introduction
Hepatocytes are unique among dierentiated parenchymal cells because they retain a stem cell-like ability to proliferate (Fausto, 2000; Michalopoulos and DeFrances, 1997) . This property underlies the remarkable capacity of the liver to regenerate following acute injuries that diminish hepatic mass. Hepatocyte proliferation is also an important adaptive response in chronic liver diseases as hepatocytes destroyed by in¯ammation and other injuries are replaced to maintain adequate liver function. Enhanced hepatocyte proliferation in acute and chronic liver diseases is associated with an improved prognosis (Delhaye et al., 1996; Fang et al., 1994) , but also may contribute to the development of hepatocellular carcinoma in the setting of cirrhosis (Tarao et al., 1994) . The factors that regulate hepatocyte proliferation have not been completely identi®ed, but are thought to include growth factors and cytokines arising from both extrahepatic sites and the liver (Fausto, 2000; Michalopoulos and DeFrances, 1997) . In the best-characterized model of hepatocyte proliferation in vivo, 70% partial hepatectomy (PH), hepatocyte proliferation in the remnant liver is associated with cell cycle protein expression similar to that observed in cell culture systems (Steer, 1995) .
Mitogens control cell cycle progression by regulating the activity of complexes consisting of cyclins and cyclin-dependent kinases (cdks) (Sherr, 1994; Sherr and Roberts, 1999) . During late G1 phase in many types of cells in culture, cyclin D1/cdk4 phosphorylates the retinoblastoma (Rb) and related p107 and p130 proteins, leading to inactivation of their growthinhibitory function and release of E2F transcription factors that promote S phase (Grana et al., 1998) . Cyclin E/cdk2 phosphorylates Rb at dierent sites than does cyclin D1/cdk4, and may synergistically promote its inactivation. However, cyclin E/cdk2 can promote cell cycle progression in the absence of Rb inactivation, suggesting that this complex acts downstream of cyclin D1/cdk4 during the G1-to S transition (Roberts, 1999) . Activation of cyclin E/cdk2 in late G1 phase is enhanced by degradation or sequestration of the p27 cdk inhibitor (Sherr and Roberts, 1999) . The essential biochemical components of the G1 restriction point have not been de®nitively identi®ed, but prior studies have shown that transfection or microinjection of speci®c proteins can trigger cell cycle progression in the absence of mitogen. These include E2F proteins, myc, skp2, cyclin E/cdk2, and cyclin D1/cdk4 (Amati et al., 1998; Connell-Crowley et al., 1998; DeGregori et al., 1997; Leone et al., 1999; Sutterluty et al., 1999) . However, in each of these studies, cell cycle progression was documented by DNA synthesis and/or FACS scanning, rather than morphologic studies to document actual progression through mitosis or an increase in cell number. Furthermore, the prior studies have been carried out in cell culture systems, which cannot accurately reproduce the complex in vivo environment.
The ability of quiescent adult hepatocytes to replicate in response to physiologic stimuli suggests that strategies to promote proliferation of these cells could be of therapeutic bene®t (Kay and Fausto, 1997) . Prior studies have demonstrated that hepatocyte proliferation can be induced in rodent models by mitogens such as hepatocyte growth factor (HGF), but the use of growth factors has not been successful in clinical situations (Fausto, 2000; Gao et al., 1999; Michalopoulos and De Frances, 1997; Phaneuf et al., 2000) . This may be due to the presence of antiproliferative factors in liver diseases, which may override mitogenic stimuli (Fausto, 2000; Michalopoulos and DeFrances, 1997 ). An alternative approach is to target cell cycle control genes acting downstream of extracellular mediators of hepatocyte proliferation. Prior studies have shown that transient transfection of cyclin D1 promotes cell cycle progression in cultured primary rat hepatocytes, in the absence of growth factor or in the presence of growth-inhibitory extracellular matrix conditions Hansen and Albrecht, 1999) . In this study, we examined strategies to promote cyclin E/cdk2 activity, to test whether this could induce hepatocyte proliferation in the absence of mitogenic signaling or cyclin D1 induction. The current studies indicate that co-transfection of cyclin E and skp2 synergistically promoted cell cycle progression in cultured hepatocytes, and was sucient to stimulate robust hepatocyte proliferation and liver hyperplasia in the intact animal. These data con®rm that a small number of genes is capable of triggering replication of quiescent cells in vivo.
Results

Hepatocyte culture studies
Cultured primary hepatocytes require mitogens such as epidermal growth factor (EGF) to proliferate, but prior studes have shown that transfection of hepatocytes with an adenovirus encoding cyclin D1 (ADV-D1) promotes cell cycle progression in the absence of mitogen . To test whether cyclin E could similarly trigger mitogen-independent cell cycle progression, rat hepatocytes were transfected with an adenovirus encoding human cyclin E (ADV-E). As is shown in Figure 1 , transfection of ADV-E resulted in signi®cant expression of the human protein, which formed complexes with rat cdk2. However, in the absence of EGF these complexes were inactive. Prior studies have shown that mitogenic stimulation of hepatocytes leads to upregulation of cyclin D1, which sequesters most p27 Sherr and Roberts, 1999) . Accordingly, EGF treatment of hepatocytes transfected with ADV-E led to diminished binding of p27 to cyclin E/cdk2, and subsequent activation of these complexes (Figure 1b,c) . However, in the absence of mitogenic stimulation, transfection with ADV-E did not promote hepatocyte cell cycle progression, presumably because of inactivation of cyclin E/cdk2 by p27.
Recent studies have shown that p27 is regulated at the level of protein stability, via a ubiquination pathway involving the F-box protein skp2 (Carrano et al., 1999; Sutterluty et al., 1999; Tsvetkov et al., 1999) . We therefore reasoned that co-transfection of skp2 with cyclin E would promote activation of the cyclin E/cdk2 kinase. As expected, transfection with an adenovirus encoding skp2 (Ad-skp2) led to diminished p27 expression ( Figure 2a ). As previously shown in ®broblasts (Sutterluty et al., 1999) . Ad-skp2 transfection led to mitogen-independent hepatocyte entry into S phase, although this response was not as robust as that seen previously with ADV-D1 (Figure 2d ,e and data not shown). Co-transfection of ADV-E and Adskp2 led to diminished p27 binding to the human cyclin E/cdk2 complex, and marked upregulation of the associated kinase activity (Figure 2b,c) . Cyclin Eskp2 co-transfection also led to activation of biochemical events associated with S phase, including expression of cyclin A and PCNA proteins, and activation of cyclin A-associated kinase activity, to levels similar to that seen after EGF stimulation (Figure 2a ,c). Cotransfection induced p21 but not cyclin D1 expression. Skp2 and cyclin E synergistically enhanced cell cycle progression, even at doses that had no eect Furthermore, the combination of ADV-E and Adskp2 overcame hepatocyte growth arrest due to a growth-inhibitory extracellular matrix, collagen gel, and the mitoinhibitory hormone transforming growth factor b (TGFb) (Figure 2e ) . Thus, co-transfection of cyclin E and skp2 decreased p27 expression, markedly activated cyclin E/ cdk2, and potently promoted cell cycle progression in cultured hepatocytes. Furthermore, these reagents stimulated cell cycle progression in the absence of cyclin D1 expression, supporting the concept that cyclin E/cdk2 acts downstream of cyclin D1/cdk4 in the cell cycle (Roberts, 1999) .
In vivo studies
Because the combination of ADV-E and Ad-skp2 transfection showed signi®cant activity in cultured hepatocytes, we tested whether these could promote cell cycle progression in vivo. Prior studies have shown that recombinant adenoviruses primarily target the liver, and transfect hepatocytes with a high eciency (Becker et al., 1994; Ilan et al., 1999) . In normal liver, hepatocytes rarely replicate, but most will enter the cell cycle after growth stimulation by 70% PH (Fausto, 2000; Michalopoulos and DeFrances, 1997) . Male BALB/c mice (7 ± 8 weeks of age) were given intravenous injections of ADV-E and Ad-skp2 or their respective control adenoviruses. As expected, cotransfection with ADV-E and Ad-skp2 led to abundant hepatic expression of their respective proteins, and resulted in cyclin E/cdk2 kinase activation (Figure 3a) .
Furthermore, cyclin E-skp2 co-transfection markedly upregulated the expression of proteins associated with cell cycle progression, including PCNA, cyclin A, and cyclin B, to levels exceeding that seen maximally after 70% PH (Figure 3b) . Similarly, cyclin A-and cyclin Bassociated kinase activity, which regulate S and M phase progression (respectively), were induced after cyclin E-skp2 co-transfection to levels substantially higher than after PH (Figure 3c ). Similar to the ®ndings in primary hepatocytes, transfection with cyclin E and skp2 upregulated p21 but not cyclin D1. from 1 ± 3 days after co-transfection, the amount of p27 protein in liver extracts diminished, although this decline was not as dramatic as seen in transfected hepatocytes in culture, possibly due to p27 expression in nonparenchymal liver cells which are not as eciently transfected by adenoviruses (Ilan et al., 1999) . At 6 days following co-transfection, both p21 and p27 were induced, which may account for the diminished cyclin-associated kinase activity observed at this time point.
Hepatic hyperplasia was grossly apparent at 6 days following co-transfection with cyclin E and skp2, and liver weight had increased by more than 50% relative to control transfection or normal liver (P50.001, Figure 4a ,b). Within 1 day after injection, more than 20% of hepatocytes had entered S phase as documented by bromodeoxyuridine (BrdU) immunohistochemistry, compared to less that 1% in mice injected with the control viruses (P50.01, Figure  4c ,g). Hepatocyte BrdU uptake remained elevated through 3 days, then declined to 2.7+1% by 6 days. The combination of cyclin E and skp2 promoted more DNA synthesis and hepatic enlargement than either vector alone (Figure 4b,c) . At 1.5 days after transfection, numerous normal-appearing hepatocyte mitoses were observed (Figure 4d,h ). These data indicate that transfection with cyclin E and skp2 was sucient to promote progression of hepatocytes through the cell cycle in vivo, and can trigger substantial hyperplasia of the liver.
Flow cytometry revealed that 1 day after cyclin Eskp2 co-transfection (but not control transfection), a substantial number of cells had entered S phase or had doubled their DNA content to 4N (Figure 4f) . At 6 days, most nuclei contained 4N or 8N DNA content, and microscopic examination revealed enlarged nuclei and atypical mitoses consistent with the division of polyploid cells (Figure 4f,j) . Polyploid hepatocytes are frequently observed during periods of physiologic hepatocyte replication such as in the developing mouse or after 70% PH (Fausto, 2000; Michalopoulos and DeFrances, 1997) , suggesting that these cells readily enter a polyploid state following mitogenic stimulation. Furthermore, the adenoviruses used in this study contained a strong constitutive promoter which resulted in sustained expression of cyclin E and activation of cyclin E/cdk2. The appearance of polyploid hepatocytes is consistent with recent studies in cell culture systems showing that sustained cyclin Eassociated kinase activation leads to the accumulation of polyploid nuclei (Garcia et al., 2000) .
Recombinant adenoviruses encoding reporter genes have previously been shown to trigger hepatocyte replication in vivo, presumably as a result of the immune response and cytokine-mediated eects on hepatic genes that promote proliferation (Ilan et al., 1999) . The control vectors did induce a low level of hepatocyte proliferation, but this was substantially less than that observed in the cyclin E-skp2 transfected mice during the ®rst 3 days. Furthermore, although moderate in¯ammation was observed at 6 days in both groups of mice, no evidence of hepatic in¯ammation was noted from 1 ± 3 days in either group (data not shown), during which time substantial hepatocyte Histologic evaluation of livers following co-transfection with cyclin E and skp2. (g) BrdU immunohistochemistry at 1 day, (h) hepatocyte mitoses (white arrows) at 1.5 days, (i) hepatocyte apoptosis (black arrow) at 3 days, (j) enlarged nuclei and atypical mitosis at 6 days proliferation occurred in the cyclin E-skp2 transfected mice. Apoptotic hepatocytes without surrounding in¯ammatory cells were observed at 2, 3 and 6 days after transfection by routine histology (Figure 4e ,i) and TUNEL staining (which revealed similar results, data not shown). Hepatocyte apoptosis can be induced by control adenoviral vectors (Ilan et al., 1999) , although this eect was greater in the cyclin E-skp2 mice than in the control mice. Apoptosis could also result from activation of cyclin/cdk kinases (Guo and Hay, 1999) , although upregulation of these kinases was readily apparent at 1 ± 1.5 days, whereas overt apoptosis was detected at 2 ± 6 days. Hepatocyte apoptosis can also be triggered by homeostatic mechanisms which resist any increase in liver mass beyond that which is ideal for the size of the animal (Fausto, 2000) , and this is a potential cause of apoptosis following hyperplasia induced by cyclin E-skp2 co-transfection.
Discussion
Well-established models from cell culture systems suggest that progression through the G1 restriction point, which requires a relatively small number of biochemical events, is sucient to trigger completion of the cell cycle (Pardee, 1989; Roberts, 1999; Sherr, 1994) . This is supported by several studies documenting that the expression of key G1/S genes can cause mitogendeprived cells in culture to enter S phase (Amati et al., 1998; Connell-Crowley et al., 1998; DeGregori et al., 1997; Leone et al., 1999; Sutterluty et al., 1999) . However, these ®ndings have not been con®rmed in an in vivo system. To our knowledge, the current study is the ®rst to show that transfection of a small number of genes can promote replication of quiescent cells in the adult animal. Of further interest is the possibility that expression of cell cycle control genes can lead to organ growth in addition to cell cycle progression, which is in distinction to some prior studies in developmental systems (Coelho and Leevers, 2000; Conlon and Ra, 1999; Neufeld et al., 1998) . The ®ndings of this study suggest that genes that promote progression through late G1 phase might also trigger the biochemical pathways necessary to increase organ mass.
Prior studies suggest that cyclin D1 plays an important role in governing progression through the G1 restriction point in hepatocytes and other cells Sher, 1994; Sher and Roberts, 1999) . However, the current results indicate that cell replication proceeded in the absence of cyclin D1 upregulation, suggesting that`downstream' events can promote completion of the cell cycle in vivo. Based on studies in other systems (Connell-Crowley et al., 1998; Geng et al., 1999; Roberts, 1999) , we suspect that activation of cyclin E/cdk2 is sucient for hepatocyte proliferation. In the current studies, activation of cyclin E/cdk2 was facilitated by co-transfection of skp2, which resulted in diminished p27 levels. This suggests that p27 is the key target of skp2, but further studies will be required to examine other potential targets. Interestingly, a recent study describing skp2-de®cient mice also demonstrated evidence of polyploid hepatocytes (Nakayama et al., 2000) . In that study, the absence of skp2 resulted in enhanced expression of cyclin E, presumably as a result of impaired degradation of this protein. However, a relatively small proportion of cyclin E (that which is unbound to cdk2) appears to be susceptible to skp2-mediated proteolysis, since prior studies have shown that transfection with skp2 does not substantially change cyclin E levels (Nakayama et al., 2000; Sutterluty et al., 1999) . Thus the relationship of skp2 to cyclin E/cdk2 is complex: skp2 destabilizes both p27 and cyclin E, and thus can contribute to the activation or inhibition of kinase activity. In the current study, forced overexpression of cyclin E along with skp2 resulted in sustained expression of human cyclin E and activation of cyclin E/ cdk2. Growing evidence indicates that skp2 and related F-box proteins play a role in governing the expression of numerous proteins that control cell cycle progression (Amati and Vlach, 1999) . Previous studies in the PH model have documented upregulation of cyclin E and skp2 following PH in rodents Bilodeau et al., 1999; Jaumot et al., 1999; Volarevic et al., 2000) , although the signi®cance of these proteins during liver regeneration has not been clearly established in knockout mice. Future studies will be necessary to de®ne the role and interaction of these proteins during the G1/S transition in hepatocytes.
Models of cell growth and proliferation suggest that growth is controlled separately from cell cycle progression (Coelho and Leevers, 2000; Conlon and Ra, 1999) . In most systems, cell mass increases during cell cycle progression, so that the daughter cells display appropriate size after mitosis. Studies in yeast, and limited data in eukaryotic systems, suggest that cell cycle genes do not automatically trigger the biosynthetic pathways necessary to increase cell mass appropriately (Coelho and Leevers, 2000) . For example, overexpression of E2F in developing Drosophila wing, which resulted in cyclin E and cdc25 overexpression, caused increased cell proliferation but not increased organ size, because proliferation was not matched with biosynthesis (Neufeld et al., 1998) . Cell size may be regulated through other growth factormediated pathways, such as the phosphoinositide 3-kinase pathway, that do not trigger a proportional increase in cell proliferation (Coelho and Leevers, 2000) . On the other hand, more recent studies in developing Drosophila indicate that cyclin D/cdk4 does promote cell growth, suggesting a link between proliferation and size at this level Meyer et al., 2000) . In the current study, cyclin E-skp2 co-transfection led to both hepatocyte proliferation and an increase in liver size, further suggesting the possibility that cell cycle genes may trigger the biosynthetic pathways required for organ growth.
We cannot exclude the possibility that cytokine release or other host response to adenoviral infection might contribute to the results observed in this study. Transfection using ®rst-generation recombinant adenoviruses has been used extensively to study biochemical pathways in the liver, and has been essential in a number of landmark papers (Becker et al., 1994; Ilan et al., 1999) . However, the host response could conceivably aect any biochemical pathway (Ginsberg, 1996) , and is a concern in all of these studies. In the current study, the proliferative response observed in mice transfected with cyclin E-skp2 was substantially greater than that seen after control transfection. Furthermore, cyclin E-skp2 potently promoted cell cycle progression in puri®ed hepatocytes in culture, where the host response is not an issue. Thus, the results suggest that the proliferative eect of ADV-E and Ad-skp2 transfection resulted from expression of the transgenes rather than the host response to the adenoviral vectors.
In severe acute and chronic liver diseases, hepatic dysfunction results in part from decreased numbers of viable hepatocytes (Kawasaki et al., 1992) . Although rare in normal liver, hepatocyte proliferation is an adaptive physiologic response in hepatic diseases, and is a determinant of survival (Delhaye et al., 1996; Fang et al., 1994) . However, in advanced liver disease, hepatocyte proliferation can be inadequate to restore normal liver function. This is thought to be due in part to inadequate mitogenic signaling, and to the presence of growth inhibitory factors such as TGFb and abnormal extracellular matrix conditions (Fausto, 2000; Michalopoulos and DeFrances, 1997) . The current data indicate that the expression of proteins which promote transition through the G1/S boundary can overcome the absence of mitogenic signals or the presence of growth inhibitors in hepatocytes. Furthermore, this study demonstrates that targeted expression of cell cycle control genes promotes hepatocyte proliferation in vivo, and suggests that similar strategies could be used therapeutically to enhance hepatocyte proliferation in liver diseases. However, it is clear that a more re®ned approach would be necessary for clinical applications. For example, vectors with less potential toxicity are under development, and systems to attain a shorter duration of transgene expression might be desirable (Chowdhury, 1999) . Even though recombinant adenoviruses produce only transient gene expression, further studies will also be necessary to rule out the possibility that temporary overexpression of pro-proliferative genes might promote the development of neoplasia. In addition, concurrent expression of G2/M regulatory genes or anti-apoptotic factors warrants further study.
Materials and methods
Adenoviruses
The construction and puri®cation of adenoviruses encoding human skp2 (Ad-skp2) and human cyclin D1 (ADV-D1), and their respective control viruses, has been previously reported Sutterluty et al., 1999) . The adenovirus encoding human cyclin E (ADV-E) was generated by ligating the KpnI-XbaI fragment of the human cyclin E cDNA (Hinds et al., 1992) into pACCMV.pLpA, followed by isolation, ampli®cation, and CsCl-density gradient centrifugation as previously described Becker et al., 1994) .
Cell culture
Primary rat hepatocytes were isolated, cultured, and transfected with adenoviruses as previously described . Hepatocytes were cultured on collagen ®lm except in the third panel of Figure 2e ), where collagen gel was used . TGFb (1 ng/ml, R&D Systems, Minneapolis, MN, USA) was added to the cells in the second panel of Figure 2e . Cells were harvested at 72 h as previously described. Flow cytometry was performed on propidium iodine (PI)-stained hepatocytes using a FACSCaliber scanner (BD Pharmingen, San Diego, CA, USA). All experiments included control transfection with ADV-bgal , which did not induce cell cycle progression or cell cycle protein expression.
Animals
Seventy per cent PH was performed on 7 ± 8 week old male BALB/c mice as previously described in (Albrecht et al., 1998) . Adenoviruses were injected at a dose of 1610 11 particles per virus (for a total of 2610 11 particles per animal, unless otherwise indicated), similar to the dosing regimen used in prior studies of hepatic gene transfer (Kozarsky et al., 1997; Phaneuf et al., 2000) . Two hours before harvest, animals received an injection of BrdU (Albrecht et al., 1998) . Livers were harvested from 1 ± 6 days later, biopsies ®xed in 10% formalin for histologic analysis, and the remainder of the tissue¯ash-frozen for biochemical studies. Routine histologic evaluation was performed by the pathology consultant (MW Stanley). Immunohistochemistry for BrdU and determination of hepatocyte mitotic rates were performed as reported elsewhere (Albrecht et al., 1998 Rai et al., 1998 . TUNEL staining was performed using the ApoTag kit (Intergen, Purchase, NY, USA) according to the manufacturer's instructions. Flow cytometry of PI stained nuclei was performed as previously described (Rudolph et al., 2000) . Five to nine animals were used for each condition at the time points shown. All animals were housed in an American Association of Accreditation of Laboratory Animal Careapproved facility and fed ad libitum.
Protein methods
Protein was isolated from cultured hepatocytes and liver tissue as previously described, followed by Western blot, immunoprecipitation, and histone H1 kinase assays using established methods Albrecht et al., 1998 . Additional antibodies include monoclonal antibodies to human cyclin E (Ab-2, Neomarkers, Fremont CA and sc-248, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and a polyclonal antibody to human skp2 (sc-7164, Santa Cruz Biotechnology). For Western blots, the expression of cdk2 was used as a loading control, since this protein is constitutively expressed in liver and hepatocytes, and varies little during proliferation Albrecht et al., 1998; Ehrenfried et al., 1997; Jaumot et al., 1999) .
